Furthermore, analyses of IL4I1 promoter methylation indicated that methylated CpGs of IL4I1 indeed decreased with tumor grade, and hypomethylation was involved in a poorer prognosis in glioma patients. The gene discussed is IL4I1; the disease is glioma.